Detalhe da pesquisa
1.
Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica
; 105(6): 1723-1730, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31439677
2.
Comparative outcomes of myeloablative and reduced-intensity conditioning allogeneic hematopoietic cell transplantation for therapy-related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation.
Am J Hematol
; 94(4): 431-438, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30597620
3.
Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study.
Biol Blood Marrow Transplant
; 24(7): 1406-1414, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29678639
4.
Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) study.
Am J Hematol
; 93(6): 769-777, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29536560
5.
Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer
; 123(14): 2671-2679, 2017 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28329410
6.
T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis.
Haematologica
; 100(4): 558-64, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25637051
7.
Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT study.
Bone Marrow Transplant
; 55(1): 224-232, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31527819
8.
Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study.
Blood Adv
; 2(16): 2127-2135, 2018 08 28.
Artigo
Inglês
| MEDLINE | ID: mdl-30143527